Related Experiment Video
Updated: Jun 25, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Adaptive designs for confirmatory clinical trials
Frank Bretz1, Franz Koenig, Werner Brannath
1Novartis Pharma AG, Lichtstrasse 35, 4002 Basel, Switzerland. franz.koeing@meduniwien.ac.at
Abstract:
Adaptive designs play an increasingly important role in clinical drug development. Such designs use accumulating data of an ongoing trial to decide how to modify design aspects without undermining the validity and integrity of the trial. Adaptive designs thus allow for a number of possible adaptations at midterm: Early stopping either for futility or success, sample size reassessment, change of population, etc. A particularly appealing application is the use of adaptive designs in combined phase II/III studies with treatment selection at interim. The expectation has arisen that carefully planned and conducted studies based on adaptive designs increase the efficiency of the drug development process by making better use of the observed data, thus leading to a higher information value per patient.In this paper we focus on adaptive designs for confirmatory clinical trials. We review the adaptive design methodology for a single null hypothesis and how to perform adaptive designs with multiple hypotheses using closed test procedures. We report the results of an extensive simulation study to evaluate the operational characteristics of the various methods. A case study and related numerical examples are used to illustrate the key results. In addition we provide a detailed discussion of current methods to calculate point estimates and confidence intervals for relevant parameters.
Insights
Adaptive designs enhance clinical drug development by using interim data for modifications, improving trial efficiency and data value. These methods optimize the drug development process through flexible trial designs.
Area of Science:
- Clinical Trials
- Biostatistics
- Drug Development
Background:
- Adaptive designs are crucial in modern clinical drug development.
- They allow modifications using accumulating data without compromising trial integrity.
- Applications include early stopping, sample size reassessment, and population changes.
Purpose of the Study:
- To review adaptive design methodology for confirmatory clinical trials.
- To explore adaptive designs for single and multiple hypotheses.
- To evaluate operational characteristics and provide practical guidance.
Main Methods:
- Review of adaptive design methodology for single and multiple hypotheses.
- Application of closed test procedures for multiple hypotheses.
- Extensive simulation study to evaluate operational characteristics.
- Case study with numerical examples for illustration.
Main Results:
- Adaptive designs increase efficiency and information value per patient.
- Methods for single and multiple hypotheses were evaluated.
- Simulation results provide insights into operational characteristics.
- Case study demonstrates practical application and key findings.
Conclusions:
- Adaptive designs offer a more efficient approach to clinical drug development.
- Careful planning and execution are essential for successful adaptive trials.
- The reviewed methods and simulations support the use of adaptive designs.
- Further discussion on point estimates and confidence intervals is provided.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.